...
首页> 外文期刊>European journal of gynaecological oncology >Prognosis and role of postmastectomy radiotherapy in patients with T1-T2 breast cancer with one to three positive axillary nodes.
【24h】

Prognosis and role of postmastectomy radiotherapy in patients with T1-T2 breast cancer with one to three positive axillary nodes.

机译:1-3个腋窝淋巴结阳性的T1-T2乳腺癌患者的乳房切除术后放疗的预后及其作用。

获取原文
获取原文并翻译 | 示例
           

摘要

PURPOSE: To evaluate the prognosis and role of postmastectomy radiotherapy (PMRT) in T1-T2 breast cancer with one to three positive axillary nodes. METHODS: The 10-year Kaplan-Meier locoregional recurrence (LRR), distant recurrence (DR), disease-free survival (DFS) and overall survival (OS) were compared between the NO and 1-3N+ cohorts. The role of PMRT was evaluated in the 1-3N+ cohort. RESULTS: The 10-year LRR, DR, DFS, OS rates in NO and the 1-3N+ cohorts were as follows: LRR 7.5% vs 19.4% (p = 0.011); DR 14.4% vs 23.0% (p = 0.029); DFS 71.3% vs 51.2% (p = 0.001) and OS 77.0% vs 58.7% (p = 0.001). Of the 192 1-3N+ patients not treated and treated with PMRT, the outcomes were: LRR 20.1% vs 18.4% (p = 0.047); DR 26.4% vs 21.5% (p = 0.743); DFS 40.2% vs 55.4% (p = 0.260) and OS 40.7% vs 66.0% (p = 0.344), respectively. CONCLUSION: PMRT reduces the 10-year LRR rate for such patients, but further examination is needed.
机译:目的:评估乳房切除术后放疗(PMRT)在腋窝淋巴结阳性为1-3个的T1-T2乳腺癌中的预后及其作用。方法:比较NO和1-3N +人群的10年Kaplan-Meier局部复发率(LRR),远处复发率(DR),无病生存期(DFS)和总生存期(OS)。在1-3N +队列中评估了PMRT的作用。结果:NO和1-3N +人群的10年LRR,DR,DFS,OS率如下:LRR 7.5%vs 19.4%(p = 0.011); DR 14.4%和23.0%(p = 0.029); DFS 71.3%vs 51.2%(p = 0.001)和OS 77.0%vs 58.7%(p = 0.001)。在192例未接受PMRT治疗的1-3N +患者中,结果为:LRR 20.1%对18.4%(p = 0.047); DR 26.4%vs 21.5%(p = 0.743); DFS分别为40.2%和55.4%(p = 0.260)和OS 40.7%和66.0%(p = 0.344)。结论:PMRT可以降低此类患者的10年LRR率,但需要进一步检查。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号